Competence Network Life Science

What Competence Network Life Science does

CONELIS e.V. (Competence Network Life Sciences) is a German non-profit association (eingetragener Verein) founded on September 10, 2009 and headquartered in Berlin at Wickenweg 24. The organization operates a curated network of approximately 40 independent expert consultants serving the pharmaceutical and life sciences industry. Membership is selective, requiring candidates to pass vetting based on referrals and professional track records. Experts cover five practice areas: Chemistry, Manufacturing and Control (CMC); Non-clinical Research and Development; Clinical Development; Regulatory Affairs and Compliance; and Business Strategy, Intellectual Property and Corporate Design. Members include senior practitioners with prior executive roles at major pharmaceutical companies including Schering AG, Bayer Schering Pharma AG, Fresenius Biotech, Medigene AG, Pharmion, AWD, Ferring, Schwarz Pharma, UCB, Bayer, and Nuvisan.

The operating model is a cooperative-style marketplace: clients browse expert profiles on conelis.org, contact experts directly by email or phone, and negotiate individual consulting contracts. Revenue from client engagements flows directly to the individual experts rather than to the association. CONELIS is funded through member dues and sustaining corporate sponsorships from approximately ten service providers including CROs (CONVIDIA, Dr. Notghi Contract Research, Sacura, Richmond Pharmacology), specialty consultancies (ConsulTech, LUMIS International, MF Biotech, biosafety4u), biostatistics firm DATAN Analytics, and clinical laboratory FyoniBio. The organization is governed by an elected executive board led by President Andreas Baumann, President-elect Hans Lindner, Past President Michael Hildebrand, and Treasurer Frank Zollmann.

The network reaches clients through direct website engagement, peer-reviewed academic publications, and member participation at industry conferences including ECTRIMS, AACR, BIO-Europe, and QP Forum. End-client segments comprise pharmaceutical companies, biotechnology firms (including gene therapy, CRISPR/Cas9, and cell therapy developers), medical device manufacturers, and life science investors. Service offerings span opportunity assessment, regulatory pathway planning, CMC strategy, clinical program design, due diligence, and licensing support across the entire drug development value chain.

Name

Competence Network Life Science

Legal name

CONELIS e.V.

Website

https://conelis.org

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

CONELIS is a German non-profit association (e.V.) operating a curated network of approximately 40 independent expert consultants serving pharmaceutical, biotechnology, medical device, and life science investor clients with specialized advice spanning drug development, regulatory affairs, clinical research, and commercialization.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Other Scientific and Technical Consulting Services (54169), Management, Scientific, and Technical Consulting Services (5416), All Other Professional, Scientific, and Technical Services (54199)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYBPAHALAH

Technical & Scientific Expert Networks

Business & Public Services/Professional Services (Legal, Accounting, Consulting)/Research, Analytics & Expert Services

SECONDARYHLAGAKAA

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGAKAJ

Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGAKAI

Clinical Quality Assurance (GCP QA, TMF/QMS oversight)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYBPAHALAB

Competitive Intelligence & Benchmarking

Business & Public Services/Professional Services (Legal, Accounting, Consulting)/Research, Analytics & Expert Services

Keywords

• Pharmaceutical consulting services
• Clinical development consulting
• Regulatory affairs consulting
• CMC consulting services
• Life science expert network

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Consulting Services: CONELIS experts provide consulting services to pharmaceutical, biotech, and life science companies. Individual experts are contracted directly by clients for specific projects or ongoing advisory roles. Revenue flows to individual consultants rather than to the association.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Competence Network Life Science (CONELIS e.V.) is a Berlin-based association of approximately 40 vetted, independent expert consultants who provide specialized consulting services to pharmaceutical, biotech, and medical device companies. The network covers five service areas across the entire drug development value chain: Chemistry, Manufacturing and Control (CMC); Non-clinical Research and Development; Clinical Development; Regulatory Affairs and Compliance; and Business Strategy, Intellectual Property and Corporate Design. Clients engage individual experts or interdisciplinary teams for project-specific or ongoing advisory engagements.

Product overview

CONELIS – Competence Network Life Sciences is not a product company but rather a network of approximately 40 highly qualified independent expert consultants offering specialized consulting services to the pharmaceutical and life sciences industry. The network covers the entire drug development value chain from early discovery to product commercialization. Services are organized into five main areas: Chemistry, Manufacturing and Control (CMC); Non-clinical Research and Development; Clinical Development; Regulatory Affairs and Compliance; and Business Strategy & Development, Intellectual Property and Corporate Design. Clients can engage individual experts or assemble interdisciplinary teams tailored to their specific project needs.

Differentiator

Problem solved

Functional benefit

Products and services

• Expert Consulting Network Services A network of approximately 40 vetted independent expert consultants offering specialized consulting services across the pharmaceutical and life sciences value chain, from early discovery through product commercialization. Clients engage individual experts or assemble interdisciplinary teams to fit project needs.
• Chemistry, Manufacturing and Control (CMC) Consulting Expert consultancy covering API synthesis, formulation development, process development for biologics, CMC regulatory strategy, GMP compliance, and Qualified Person (QP) support for pharmaceutical products.
• Non-clinical Research and Development Consulting Expert services including preclinical drug development program design, disease-specific target identification, pharmacodynamics, pharmacokinetics, ADME studies, safety pharmacology, and regulatory toxicology.
• Clinical Development Consulting Expert services covering clinical program and study design (Phases I-IV), biostatistics, data management, drug safety, medical affairs, regulatory submissions, and interim management.
• Regulatory Affairs and Compliance Consulting Expert services for navigating regulatory pathways, including regulatory strategy, submissions to authorities (EMA, FDA), GLP/ISO compliance, pharmacovigilance, and quality systems implementation.
• Business Strategy, Intellectual Property and Corporate Design Consulting Expert services for commercial assessment, market research, portfolio evaluation, in-licensing/out-licensing support, due diligence, intellectual property law, and corporate visual design.

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

16 partnerships are on record, tiered minor and core.

• CONVIDIA clinical researchminorOthersCONVIDIA clinical research GmbH is a full-service employee-owned CRO with 15 years extensive working experience, offering clinical studies Phase II-IV, non-interventional studies, quality management, and medical writing. Listed as a sustaining member supporting CONELIS.
• ConsulTech GmbHminorOthersProvides advice on financing research and development projects with grants in biotechnology, pharmaceuticals, medical technology and IT services for life sciences. Listed as a sustaining member supporting CONELIS.
• LUMIS InternationalminorOthersSpecialized to provide start up and market entry services for small biopharmaceutical companies conducting clinical trials in Europe. Offers legal representation, vendor management, and scientific support. Listed as sustaining member.
• Dr. Notghi Contract ResearchminorOthersFull service CRO in Berlin with 20 years experience offering services for pharmaceuticals, consumer healthcare/OTC, and medical devices including full clinical trials services, pharmacovigilance, and regulatory support.
• SacuraminorOthersFull service CRO experienced in 120 clinical trials and 70 indications, offering clinical study set-up, management, monitoring, regulatory support, and data/document management. Listed as sustaining member.
• biosafety4uminorOthersAdministrative services for laboratories including biosafety genetic engineering services, consulting, occupational safety, GLP/GCLP/GCP quality management, and regulatory liaison. Listed as sustaining member.
• Richmond PharmacologycoreOthersEarly phase CRO with specialist focus on Adaptive, Cardiac Safety, Japanese and Patient Studies. MHRA accredited hospital based trials unit providing full clinical trial service. Listed as sustaining member. Notable collaboration on CRISPR gene editing trials.
• MF BiotechcoreOthersMF BIOTECH specializes in strategic project leadership and consulting for innovative biopharmaceutical development including CAR-T, GMO, mRNA, protein drugs, and bacteriophages. Listed as sustaining member with Michael Firgens as founder.
• FyoniBio GmbHminorOthersISO 9001 certified clinical laboratory offering customized assays following GCLP standards including PK, anti-drug antibody, biomarker assays, and mass spectrometry analysis. Listed as sustaining member.
• Richmond Research InstitutecoreStrategic or Co-development PartnerAcademic research institute dedicated to understanding and improving safety of pharmaceuticals. Collaboration with St George's University of London and other academic institutions including King's College London, Liverpool School of Tropical Medicine, Aalborg Universitet, and Toho University. Led by Dr Jorg Taubel.
• St George's University of LondoncoreStrategic or Co-development PartnerAcademic partner of Richmond Research Institute for clinical pharmacology research and education. Collaboration on cardiac health, clinical trial designs, hepatology, and ethnic/sex differences research.
• CombiGene ABminorStrategic or Co-development PartnerSwedish gene therapy company developing AAV-based treatment for epilepsy and partial lipodystrophy. Accelero Bioanalytics provides bioanalytical support including biodistribution and shedding analysis. Eurostars funding of EUR 882,500 allocated to CGT2 project.
• Intellia TherapeuticscoreStrategic or Co-development PartnerBiotechnology company developing CRISPR/Cas9 gene editing therapies. Richmond Pharmacology conducted first-in-human trial of NTLA-2001 for Transthyretin Amyloidosis (ATTR) treatment.
• Royal Free HospitalminorStrategic or Co-development PartnerPartnered with Richmond Pharmacology and Intellia Therapeutics in landmark CRISPR/Cas9 clinical trial of NTLA-2001 for ATTR treatment.
• ITCC-P4minorStrategic or Co-development PartnerPediatric cancer research consortium. EPO Berlin-Buch provides access to over 400 well-characterized patient-derived pediatric PDX models through collaboration with ITCC-P4.
• Gläsernes Labor AkademieminorChannel Partner/ Reseller/ DistributorCampus Berlin-Buch training provider. CONELIS members present at the 'From Target to Market' Biotech & Pharma Summer School organized by Gläsernes Labor. Joint educational events and networking.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PharmaLex (Cencora): Regulatory affairs and development consulting firm, now part of Cencora/Alliance Healthcare. Most directly comparable peer for CONELIS's regulatory strategy, submissions, and quality management consulting offerings.
• Parexel International: Global CRO offering regulatory, clinical, and CMC consulting services to pharma and biotech. Directly comparable to CONELIS in regulatory affairs and clinical development consulting, though at vastly larger scale with FTE resourcing rather than independent expert networks.
• ProPharma Group: Specialized regulatory, compliance, and quality consulting firm serving pharma and biotech. Comparable to CONELIS's regulatory affairs, GxP compliance, and CMC service lines, particularly for mid-market and small-cap clients.
• Alacrita Life Science Consulting: Boutique life sciences consulting firm offering strategic and operational support across drug development. Closest comparable in scale and model to CONELIS, including due diligence, opportunity assessment, and CMC/regulatory advisory work.

Broad incumbents

• ICON plc: Large global CRO providing clinical development, biometrics, regulatory, and laboratory services. Comparable to CONELIS's clinical development and regulatory service areas at enterprise scale, with established sustaining partner relationships across Europe.
• Charles River Laboratories: Global CRO and life sciences services firm covering preclinical, CMC, and clinical research. Overlaps with CONELIS's non-clinical R&D and CMC consulting areas, particularly for biotech clients developing novel modalities.
• IQVIA: World's largest life sciences services and consulting firm spanning clinical, regulatory, R&D, and commercial. Overlaps with CONELIS's full value-chain coverage but operates as a scaled incumbent across all five CONELIS service areas plus technology/analytics.

Others

• GLG (Gerson Lehrman Group): Large expert network connecting clients with vetted professionals for consulting engagements across industries including healthcare. Functions as an expert-marketplace platform—the digital-network model CONELIS could be disrupted by or evolve toward.
• Guidepoint: Global expert network providing on-demand consultations to businesses, including dedicated life sciences practice. Alternative expert-network model against which CONELIS's curated senior-expert approach must differentiate.

Regional players

• Dr. Notghi Contract Research: Berlin-based full-service CRO with 20 years' experience offering clinical trials, pharmacovigilance, and regulatory support. Existing CONELIS sustaining member and direct overlap in Berlin-based clinical and regulatory services for European clients.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Competence Network Life Science